Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AC Immune S.A.
(NQ:
ACIU
)
3.000
-0.030 (-0.99%)
Streaming Delayed Price
Updated: 11:14 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
34,540
Open
3.070
Bid (Size)
3.000 (1)
Ask (Size)
3.030 (4)
Prev. Close
3.030
Today's Range
3.000 - 3.180
52wk Range
1.780 - 5.140
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ACIU Stock Earnings: AC Immune Beats EPS, Beats Revenue for Q4 2023
March 14, 2024
ACIU stock results show that AC Immune beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
March 14, 2024
From
AC Immune SA
Via
GlobeNewswire
Performance
YTD
-36.03%
-36.03%
1 Month
-20.42%
-20.42%
3 Month
-39.64%
-39.64%
6 Month
N/A
N/A
1 Year
+29.87%
+29.87%
More News
Read More
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
February 22, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
January 22, 2024
From
AC Immune SA
Via
GlobeNewswire
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
January 03, 2024
From
AC Immune SA
Via
GlobeNewswire
Why Shares of AC Immune Jumped This Week
June 30, 2023
Via
The Motley Fool
Why AC Immune Stock Skyrocketed Today
June 27, 2023
Via
Benzinga
AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial
December 15, 2023
Via
Benzinga
AC Immune Announces Pricing of Underwritten Offering of Common Shares
December 15, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
December 15, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
December 01, 2023
From
AC Immune SA
Via
GlobeNewswire
Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
November 28, 2023
Via
InvestorPlace
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Via
Benzinga
AC Immune to Present at the Jefferies 2023 London Healthcare Conference
November 07, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
November 03, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
November 02, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
October 27, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
October 17, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
October 05, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
September 05, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
August 04, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
July 28, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune SA Appoints New Chief Medical Officer
July 26, 2023
From
AC Immune SA
Via
GlobeNewswire
AC Immune Showcasing Precision Medicine Programs at AAIC 2023
July 03, 2023
From
AC Immune SA
Via
GlobeNewswire
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 27, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.